The mission of the Chicago Biomedical Consortium (CBC) is to stimulate collaboration among scientists at Northwestern University, The University of Chicago, the University of Illinois Chicago and other Chicagoland institutions to accelerate discovery and expand the Chicago based life sciences ecosystem in order to transform life science research into biomedical applications, create inclusive Chicagoland opportunities, and improve the health of humankind.

The CBC gratefully acknowledges support from the Searle Funds at The Chicago Community Trust.

▸ RFA: Entrepreneurial Fellows Award

Updated: May 11, 2024
The CBC Entrepreneurial Fellows (EF) Award program identifies and supports the professional development of junior life sciences researchers who are keen to develop the skills and experiences needed to move translational projects from a university lab toward commercialization and potentially into a Chicago-based biotech start-up. The program exposes Fellows to a breadth of real-world experiences across the CBC institutions and connects trainees to the Chicago biomedical community.

The CBC Entrepreneurial Fellows (EF) Award application submission portal is CLOSED. closed on May 10, 2024.
Visit us regularly to see when the next round of application submissions will start!

Meet the CBC Entrepreneurial Fellows HERE!

Read more

▸ RFA: Accelerator Award

Updated: January 10, 2024
The Accelerator Award is a milestone-driven award program (up to $250,000) focused on translational research toward therapeutics or associated biomarkers and diagnostics.

The Accelerator Award Letter of Intent (LOI) submission portal is now OPEN;
LOI submissions will be accepted on a rolling basis.

Read more

▸ RFA: Oncology Affinity Group Award

Updated: January 10, 2024
The CBC Oncology Affinity Group is an inclusive community of Chicago scientists with an overarching goal to provide a framework for selecting high-risk/high-reward research projects in the Oncology space. The CBC Oncology Affinity Group award can range up to $250,000 total for use over one to two years.

The Letter of Intent (LOI) submission portal for the CBC Oncology Affinity Group is now CLOSED. LOI submission deadline: TBA.

Check back soon for more information about the next Affinity Group schedule.

Read more

More programs

Recent Twitter Posts


Recent CBC News

News  I  November 7, 2023

▸ CBC-HITES: New Chicago biopharma hub will accelerate timeline from medical discovery to patient delivery

CBC-HITES, in partnership with 27 industry, venture capital and community organizations, is one of 13 hubs that are now part of the NIH’s Research Evaluation and Commercialization Hub (REAC Hub) program.

Find out how CBC-HITES will help academic inventors from nine Chicago institutions partner with biopharma leaders to transform their research into commercial products.

▸ Read more

CBC In The News I November 6, 2023

▸ The Chicago BioCapital Summit showcases Chicago’s latest innovations in the life sciences and biotech space.

Play the video below for highlights of the November 2, 2023 event!

Video produced by Ahmed Disouky @ CBC, 2023

▸ Read more

News I October 25, 2023

▸ The Chicago Biomedical Consortium Announces Funding Renewal for Ambitious Phase 3 Plans to Support the Growing Life Science Industry in Chicagoland

With an additional $13.5 million of funding from the Searle Funds at The Chicago Community Trust, the Chicago Biomedical Consortium (CBC) is entering its 3rd Phase of operations. The CBC will continue its funding of high-quality, inter-institutional academic projects in this next phase.

▸ Read more

▸ More news


Community, Biotech, & Entrepreneurship

Check back soon!

More community, biotech & entrepreneurship


Check back soon!

More opportunities